Musashi-1 Is a Novel Immunohistochemical Marker of Neuroendocrine Carcinoma of the Lung
Small cell lung cancer (SCLC) and large cell neuroendocrine carcinoma (LCNEC) have recently been grouped as lung neuroendocrine carcinomas (NECs). Because these lung NECs are clinically malignant and their treatment strategies differ from those of non-SCLC, the quality of diagnosis has a significant...
Main Authors: | Yu Izaki, Vishwa Jeet Amatya, Takahiro Kambara, Kei Kushitani, Yoshihiro Miyata, Morihito Okada, Yukio Takeshima |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-11-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/15/23/5631 |
Similar Items
-
Impact of Musashi-1 and Musashi-2 Double Knockdown on Notch Signaling and the Pathogenesis of Endometriosis
by: Theresa Strauß, et al.
Published: (2022-03-01) -
Musashi and Plasticity of Xenopus and Axolotl Spinal Cord Ependymal Cells
by: Ellen A. G. Chernoff, et al.
Published: (2018-02-01) -
RNA binding proteins in spermatogenesis: an in depth focus on the Musashi family
by: Jessie M Sutherland, et al.
Published: (2015-01-01) -
Expression of neuroendocrine markers in endometrial carcinomas — an immunohistochemical analysis
by: Witold Kędzia, et al.
Published: (2012-07-01) -
Small Molecule Palmatine Targeting Musashi-2 in Colorectal Cancer
by: Xue Zhang, et al.
Published: (2022-01-01)